DMT as a stroke treatment?
May 02, 2023•26 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
DMT (N.N-Dimethyltryptamine) is a hallucinogenic tryptamine drug which naturally occurs in plant species such as Psychotria viridis or Chacruna. It can also be made in a laboratory.
We speak with Algernon Pharmaceuticals CEO, Christopher J. Moreau, on how they are trialling DMT as a treatment for stroke.
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android